Spectrogen Pharmachem Limited, a active public limited company, was established on 22 December 2020 in Tirumalagiri, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24299TG2020PLC147109. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹14.00 Cr and a paid-up capital of ₹9.62 Cr.
Formerly known as Spectrogen International Private Limited. It upholds a compliant status. Its leadership includes Srinivasa Raju Marni (Whole-Time Director), Gundluru Reddeppa (Director), Vyasmurti Madhavrao Shingatgeri (Director). Past directors included Srinivasa Raju Marni, Leela Reddy Konda, Swapneswar Mishra. It holds ₹1.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at First Floor, Sy. 115, Brig Sayeed, Hanumanji Colony, Bowenpally, Tirumalagiri, Telangana, 500009.
U24299TG2020PLC147109
147109
22 December 2020
₹14.00 Cr
₹9.62 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Spectrogen Pharmachem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasa Raju Marni | Whole-Time Director | 16 Mar 2023 | Current |
| Gundluru Reddeppa | Director | 17 Jan 2024 | Current |
| Vyasmurti Madhavrao Shingatgeri | Director | 03 Feb 2024 | Current |
| Bhushanam Busi | Managing Director | 17 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 05 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 05 Feb 2024 | Past |
| Pramod Abcsdd | Additional Director | 22 Aug 2022 | Past |
| Pramod Abcsdd | Director | 25 Mar 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Spectrogen Pharmachem Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.73% decrease. The company also saw a substantial improvement in profitability, with a 518.28% increase in profit. The company's net worth Soared by an impressive increase of 293.84%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Spectrogen Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹16,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2021 | Others | ₹1.65 Cr | Open |
Explore comprehensive loan charge details -
Spectrogen Pharmachem has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Spectrogen Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrogen Pharmachem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Spectrogen Pharmachem Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Spectrogen Pharmachem Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
Vyasmurti Madhavrao Shingatgeri was appointed as a Director was appointed as a Director on 03 Feb 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
Mounika Arshakota was appointed as a Cfo was appointed as a Cfo on 30 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The activity Gundluru Reddeppa was appointed as a Director was appointed as a Director on 17 Jan 2024 & has been associated with this company since 1 year 10 months . was completed.
Bhushanam Busi was appointed as a Managing Director was appointed as a Managing Director on 17 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The CIN of Spectrogen Pharmachem Limited is U24299TG2020PLC147109.
Spectrogen Pharmachem Limited is headquartered at First Floor, Sy. 115, Brig Sayeed, Hanumanji Colony, Bowenpally, Tirumalagiri, Telangana, 500009.
Spectrogen Pharmachem Limited was incorporated on 22 December 2020.
The current directors of Spectrogen Pharmachem Limited are
The primary industry of Spectrogen Pharmachem Limited is Trade.
Spectrogen Pharmachem Limited is unlisted.
The authorized capital of Spectrogen Pharmachem Limited is ₹14.00 Cr, and the paid-up capital is ₹9.62 Cr.
The compliance status of Spectrogen Pharmachem Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX